Insider Transactions in Q1 2022 at Reata Pharmaceuticals Inc (RETA)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 03
2022
|
Martin Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
59
+50.0%
|
$1,593
$27.32 P/Share
|
|
Jan 03
2022
|
William D. Mc Clellan Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
59
+50.0%
|
$1,593
$27.32 P/Share
|
|
Jan 03
2022
|
Shamim Ruff Director |
BUY
Grant, award, or other acquisition
|
Direct |
118
+50.0%
|
$3,186
$27.32 P/Share
|
|
Jan 03
2022
|
Michael D Wortley Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+50.0%
|
-
|
|
Jan 03
2022
|
Manmeet Singh Soni COO, CFO and President |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+42.02%
|
-
|
|
Jan 03
2022
|
Colin John Meyer Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+40.23%
|
-
|
|
Jan 03
2022
|
Dawn Carter Bir Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+50.0%
|
-
|
|
Jan 03
2022
|
Bhaskar Anand SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+43.1%
|
-
|